Literature DB >> 18023685

Predictors of paroxysmal atrial fibrillation in patients undergoing aortic valve replacement.

Maciej Banach1, Aleksander Goch, Malgorzata Misztal, Jacek Rysz, Ryszard Jaszewski, Jan Henryk Goch.   

Abstract

OBJECTIVE: Atrial fibrillation is one of the most common complications after cardiac surgery. This study evaluates the risk factors of paroxysmal atrial fibrillation in patients who underwent aortic valve replacement.
METHODS: The study comprised 300 patients with aortic valve defects of either aortic stenosis (n = 150) or regurgitation (n = 150) who underwent aortic valve replacement. For each patient, 2-mode and Doppler echocardiographic examinations were performed in the preoperative period, early postoperative period, and long-term observation, and selected hemodynamic parameters were analyzed.
RESULTS: Factors significantly associated with atrial fibrillation in patients with aortic stenosis were heart failure (odds ratio = 5.5), age 70 years or more (4.5), low (3.9) and high body mass index (1.7), maximal transvalvular gradient (3.7), low left ventricular ejection fraction (5.1), end-systolic (2.9) and end-diastolic intraventricular septum thickness (1.5), and insignificant mitral regurgitation (1.9) in the preoperative period; and left ventricular ejection fraction (4.4) and end-systolic intraventricular septum thickness (1.8) in the early postoperative period. In the aortic regurgitation group, factors significantly associated with atrial fibrillation were age (1.8), left ventricular ejection fraction (3.7), left ventricular end-systolic diameter (1.7), end-diastolic intraventricular septum thickness (1.7), left atrium dimension (4.1) and insignificant mitral regurgitation (2.5) in the postoperative period; essential arterial hypertension (3.3), diabetes mellitus (2.6), and heart failure in the history (4.5) in the preoperative period; and left ventricular ejection fraction (1.9) and left atrium dimension (2.9) in the early postoperative period.
CONCLUSION: On the basis of the separated risk factors, all patients should be preoperatively classified to applicable groups of risk of postoperative atrial fibrillation appearance, and the prophylactic treatment should be administered in the group of patients with the highest risk. It may essentially decrease the rate of complications and deaths, and, consequently, the costs of postoperative medical care.

Entities:  

Mesh:

Year:  2007        PMID: 18023685     DOI: 10.1016/j.jtcvs.2007.08.032

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  Atrial fibrillation following aortic valve replacement: impact of perioperative use of intravenous β-blocker.

Authors:  Junki Yokota; Hiroyuki Nishi; Naosumi Sekiya; Mitsutomo Yamada; Toshiki Takahashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-12-20

2.  Incidence of postoperative atrial fibrillation in transdermal β-blocker patch users is lower than that in oral β-blocker users after cardiac and/or thoracic aortic surgery.

Authors:  Homare Okamura; Mamoru Arakawa; Atsushi Miyagawa; Hideo Adachi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-05-02

3.  Left Atrial Volume and Post-Operative Atrial Fibrillation after Aortic Valve Replacement.

Authors:  Yeruva Madhu Reddy; Ruby Satpathy; Xuedong Shen; Mark Holmberg; Claire Hunter; Aryan Mooss; Dennis Esterbrooks
Journal:  J Atr Fibrillation       Date:  2010-12-15

Review 4.  Atrial Fibrillation: The New Epidemic of the Ageing World.

Authors:  Wilbert S Aronow; Maciej Banach
Journal:  J Atr Fibrillation       Date:  2009-04-01

5.  Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.

Authors:  Martin B Leon; Nicolo Piazza; Eugenia Nikolsky; Eugene H Blackstone; Donald E Cutlip; Arie Pieter Kappetein; Mitchell W Krucoff; Michael Mack; Roxana Mehran; Craig Miller; Marie-Angèle Morel; John Petersen; Jeffrey J Popma; Johanna J M Takkenberg; Alec Vahanian; Gerrit-Anne van Es; Pascal Vranckx; John G Webb; Stephan Windecker; Patrick W Serruys
Journal:  Eur Heart J       Date:  2011-01-06       Impact factor: 29.983

6.  Intraoperative loading dose of amiodarone for prophylaxis against atrial fibrillation after valvular heart surgery.

Authors:  Yasser Mohamed Amr; Elsayed M Elmistekawy; Abd-Almohsen M Hammad
Journal:  Anesth Essays Res       Date:  2010 Jul-Dec

7.  The perioperative effect of magnesium sulfate in patients with concentric left ventricular hypertrophy undergoing cardiac surgery: A double-blinded randomized study.

Authors:  Rabie Soliman; Walid Abukhudair
Journal:  Ann Card Anaesth       Date:  2019 Jul-Sep

8.  A novel predictive model for new-onset atrial fibrillation in patients after isolated cardiac valve surgery.

Authors:  Heng Yang; Chen Yuan; Juesheng Yang; Haiyan Xiang; Wanqi Lan; Yanhua Tang
Journal:  Front Cardiovasc Med       Date:  2022-09-29

9.  The mechanisms of atrial fibrillation in hyperthyroidism.

Authors:  Agata Bielecka-Dabrowa; Dimitri P Mikhailidis; Jacek Rysz; Maciej Banach
Journal:  Thyroid Res       Date:  2009-04-02

10.  Dose-response relationship among body mass index, abdominal adiposity and atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of 35 cohorts.

Authors:  Menglu Liu; Kaibo Mei; Lixia Xie; Jianyong Ma; Peng Yu; Siquan Niu; Ya Xu; Yujie Zhao; Xiao Liu
Journal:  PeerJ       Date:  2021-07-21       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.